Loading
Every trade that managers of מדיפאואר disclose to TASE (ISA) is tracked on this page. Over the twelve months to 18 October 2026, 27 filings were filed, from 12 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Over the last twelve months, not one insider purchase of מדיפאואר stock was filed.
With 27 filings in twelve months, the company is more active than the median of 13 filings across the 530 companies we follow on the same exchange.
Every figure here comes from the filings published by TASE (ISA) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 27 declarations
Medipower is a publicly traded company on the Tel Aviv Stock Exchange, specializing in the energy sector. It focuses on developing innovative energy solutions.
Insider filings
Over the last 90 days, 9 filings published between 8 September and 15 October 2026: no open-market purchase or sale filed by an insider. 9 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 17 October 2026 (UTC)